Radiance Biopharma

Radiance Biopharma is dedicated to developing mono/bispecific antibody-drug conjugates (ADCs) for the treatment of cancer and other unmet medical needs. Dr. Marc Lippman, Co-Founder and Chairman of the Board of Radiance Biopharma, is a renowned oncologist and former founding board member of Seagen (the leading company in the ADC field, recently acquired by Pfizer). Headquartered in Boston, Massachusetts, USA, Radiance Biopharma boasts a world-class and highly experienced leadership team, bringing together top talents with outstanding achievements in ADC engineering, clinical development, and management.